Abstract:Diabetes mellitus (DM) is becoming a lifestyle-related pandemic disease. Diabetic patients frequently develop electrolyte disorders, especially diabetic ketoacidosis or nonketotic hyperglycemic hyperosmolar syndrome. Such patients show characteristic potassium, magnesium, phosphate, and calcium depletion. In this review, we discuss a homeostatic mechanism that links calcium and DM. We also provide a synthesis of the evidence in favor or against this linking mechanism by presenting recent clinical indications, … Show more
“…Regarding the effect of the HG condition on calcium signaling, previous studies have suggested an altered calcium homeostasis in diabetics animals (Ahn, Kang, & Jeung, ; Pereira et al, ; Sorrentino et al, ). In cardiomyocytes, a deregulation of Ca 2+ cycling and diminished Ca 2+ influx have been shown under diabetic conditions (Bergh, Hjalmarson, Sjögren, & Jacobsson, ; Lu et al, ; Pereira et al, ).…”
One of the tissues of the central nervous system most affected by diabetes is the retina. Despite a growing understanding of the biochemical processes involved in glucose toxicity, little is known about the physiological consequences of chronic high
“…Regarding the effect of the HG condition on calcium signaling, previous studies have suggested an altered calcium homeostasis in diabetics animals (Ahn, Kang, & Jeung, ; Pereira et al, ; Sorrentino et al, ). In cardiomyocytes, a deregulation of Ca 2+ cycling and diminished Ca 2+ influx have been shown under diabetic conditions (Bergh, Hjalmarson, Sjögren, & Jacobsson, ; Lu et al, ; Pereira et al, ).…”
One of the tissues of the central nervous system most affected by diabetes is the retina. Despite a growing understanding of the biochemical processes involved in glucose toxicity, little is known about the physiological consequences of chronic high
“…Moreover, insulin release is a process dependent on calcium, and as low vitamin D levels can lead to hypocalcaemia, this can also disrupt insulin secretion . Vitamin D regulates extracellular calcium to ensure normal calcium influx, thereby enhancing insulin action and signal transduction .…”
Vitamin D deficiency has been implicated in the pathophysiology of cardiometabolic disorders including obesity, type 2 diabetes mellitus, cardiovascular diseases and polycystic ovary syndrome. Despite a large number of experimental and observational studies supporting a role for vitamin D in these pathologies, randomized controlled trials have reported little to no effect of vitamin D supplementation in the prevention or treatment of these disorders, although some results remain ambiguous. Polymorphisms in genes related to vitamin D metabolism, particularly in the vitamin D receptor and binding protein and the metabolizing enzyme 1-α-hydroxylase, have emerged as potential contributors to these divergent results. It is now becoming increasingly recognized that the effects and potential benefits of vitamin D supplementation may vary by several factors including vitamin D deficiency status, ethnicity and/or the presence of genetic variants, which affect individual responses to supplementation. However, these factors have seldom been explored in the available literature. Future trials should consider inter-individual differences and, in particular, should aim to clarify whether certain subgroups of individuals may benefit from vitamin D supplementation in the context of cardiometabolic health.
“…Associations between IHP and T2DM are not well understood as IHP is a rare disease, with a period prevalence of 7.2 per million population in Japan 10. Although previous in vitro and in vivo studies have reported on the importance of extracellular calcium concentrations for insulin secretion,11–15 the insulin secretion levels following glucagon stimulation tests did not increase after the treatment of hypocalcaemia in this case (table 3); this suggested that the diabetes was not secondary to hypocalcaemia. The low PTH levels may have weakened insulin secretion in this case, as in vitro studies have shown that PTH (1–34) directly stimulates insulin release from pancreatic islets through the stimulation of cyclic adenosine monophosphate (cAMP) production or activation of protein kinase C 16 17.…”
We report a rare case of type 2 diabetes mellitus (T2DM) complicated with idiopathic hypoparathyroidism. A 36-year-old Japanese man was admitted to our hospital owing to poor glycaemic control and hypocalcaemia. The patient had myalgia resulting from hypocalcaemia, which prevented adequate exercise. He considered the onset of myalgia to be an adverse event of oral hypoglycaemic agents and reduced compliance to medication; however, his serum calcium level was never measured. Treatment for hypocalcaemia immediately improved the myalgia, facilitating regular exercise therapy and ensuring compliance with prescribed medications, as the now-resolved myalgia was no longer perceived to be an adverse effect of glucose-lowering agents; this improved glycaemic control. Although hypoparathyroidism is a rare disease, it is necessary to assess serum calcium levels in patients with T2DM, particularly in cases presenting with unidentified complaints such as myalgia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.